Lumos Pharma Statistics Share Statistics Lumos Pharma has 8.65M
shares outstanding. The number of shares has increased by 6.46%
in one year.
Shares Outstanding 8.65M Shares Change (YoY) 6.46% Shares Change (QoQ) 0% Owned by Institutions (%) 25.08% Shares Floating 5.66M Failed to Deliver (FTD) Shares 2,448 FTD / Avg. Volume 2.38%
Short Selling Information The latest short interest is 54.33K, so 0.63% of the outstanding
shares have been sold short.
Short Interest 54.33K Short % of Shares Out 0.63% Short % of Float 0.87% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.76 and the forward
PE ratio is -2.75.
Lumos Pharma's PEG ratio is
-0.06.
PE Ratio -0.76 Forward PE -2.75 PS Ratio 12.63 Forward PS 36.6 PB Ratio 0.95 P/FCF Ratio -0.83 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lumos Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.69,
with a Debt / Equity ratio of 0.02.
Current Ratio 5.69 Quick Ratio 5.69 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $68.37K Profits Per Employee $-1.13M Employee Count 30 Asset Turnover 0.05 Inventory Turnover n/a
Taxes Income Tax -29K Effective Tax Rate 0.09%
Stock Price Statistics The stock price has increased by 92.89% in the
last 52 weeks. The beta is 0.33, so Lumos Pharma's
price volatility has been higher than the market average.
Beta 0.33 52-Week Price Change 92.89% 50-Day Moving Average 4.22 200-Day Moving Average 3.1 Relative Strength Index (RSI) 55.58 Average Volume (20 Days) 102,979
Income Statement In the last 12 months, Lumos Pharma had revenue of 2.05M
and earned -34.03M
in profits. Earnings per share was -4.18.
Revenue 2.05M Gross Profit 2.05M Operating Income -36.61M Net Income -34.03M EBITDA -36.57M EBIT -36.61M Earnings Per Share (EPS) -4.18
Full Income Statement Balance Sheet The company has 35.08M in cash and 585K in
debt, giving a net cash position of 34.49M.
Cash & Cash Equivalents 35.08M Total Debt 585K Net Cash 34.49M Retained Earnings -161.52M Total Assets 17.46M Working Capital 10.77M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -31.09M
and capital expenditures 0, giving a free cash flow of -31.09M.
Operating Cash Flow -31.09M Capital Expenditures n/a Free Cash Flow -31.09M FCF Per Share -3.82
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -1785.18% and -1659.39%.
Gross Margin 100% Operating Margin -1785.18% Pretax Margin -1660.8% Profit Margin -1659.39% EBITDA Margin -1783.03% EBIT Margin -1785.18% FCF Margin -1516.09%
Dividends & Yields LUMO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for LUMO is $4.25,
which is -2.1% lower than the current price. The consensus rating is "Hold".
Price Target $4.25 Price Target Difference -2.1% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 19, 2020. It was a
backward
split with a ratio of 1:9.
Last Split Date Mar 19, 2020 Split Type backward Split Ratio 1:9
Scores Altman Z-Score -19.2 Piotroski F-Score 3
